Woman with rare autoimmune disorder successfully treated during pregnancy
New Delhi, July 24 (IANS) Bengaluru doctors successfully treated a 32-year-old woman with a rare autoimmune disease amid her pregnancy. Autoimmune disorders like Factor 13 acquired deficiency can complicate pregnancies, as antibodies generated by the mother may affect foetal development, particularly the heart. Factor 13 deficiency is exceedingly rare, occurring in approximately 1 in 2-3
New Delhi, July 24 (IANS) Bengaluru doctors successfully treated a 32-year-old woman with a rare autoimmune disease amid her pregnancy.
Autoimmune disorders like Factor 13 acquired deficiency can complicate pregnancies, as antibodies generated by the mother may affect foetal development, particularly the heart.
Factor 13 deficiency is exceedingly rare, occurring in approximately 1 in 2-3 million individuals, and requires specialised care.
The patient, Shradha (name changed), faced multiple fertility challenges due to the autoimmune disorders, including ANA (antinuclear antibody), APL (antiphospholipid antibody), and NK cell deficiency.
Despite undergoing multiple treatments like IUI and IVF, she experienced three consecutive miscarriages.
It was during her second miscarriage, that Shradha was diagnosed with the rare condition, which necessitated the use of blood thinners throughout pregnancy.
Shradha’s pregnancy journey was fraught with complications, including frequent bleeding episodes. She conceived naturally on her fourth attempt but continued to face challenges, including spontaneous bleeding.
“The rare condition of inhibitors to Factor 13 leads to deficiency. This is not inherited but can develop due to pre-existing autoimmune conditions. Managing pregnancy with Factor 13 deficiency is exceptionally rare, especially when complicated by acquired inhibitors,” said Dr. Poornima M Gowda, Consultant Obstetrician and Gynecologist at Cloudnine Hospital, Benagaluru.
The treatment involved regular blood transfusions to maintain stable Factor 13 levels. Despite the challenges, Shradha delivered a baby girl prematurely at 34 weeks.
The baby, now over six months old, is doing well, said Dr. Poornima.
The chances of the baby developing the same problem are minimal, as the condition is not genetic but will be monitored, she added.
–IANS
ts/rvt/rad
Councillors Meet BJD President Naveen Patnaik after Defeating BJP Chairperson of Phulbani Municipality in No-confidence Motion
Next ArticleBJD MP Demands Inclusion of Ho, Mundari, Bhumij, Kui, Saora and Kosli Languages in 8th Schedule of Constitution
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
